From the Department of Nuclear Medicine, PET/CT Unit, Gulf International Cancer Center, Abu Dhabi, United Arab Emirates.
Received for publication May 23, 2022; revision accepted July 24, 2022.
Conflicts of interest and sources of funding: none declared.
Correspondence to: Yazan Z. Alabed, MD, PhD, Department of Nuclear Medicine, PET/CT Unit, Gulf International Cancer Center, PO Box 5882, Abu Dhabi, United Arab Emirates. E-mail: [email protected].
